Chief Engagement & Information Officer • Swiss Board Certified • Purpose-driven & Mountaineer
As the Gavi, the Vaccine Alliance Board meets in Indonesia this week, here are some 📊 fascinating insights from Indonesia's immunization landscape - a critical player in global health: Indonesia, with its nearly 5M annual birth cohort, presents both significant opportunities and challenges in vaccine delivery. Here are some key takeaways from a recent country analysis: 🔍 Key highlights: - Ambitious expansion plans: National scale-up of HPV, Rotavirus, and IPV2 vaccines planned for 2023 - Strong domestic focus: 94% of the $2.1B immunization program (2020-2024) is domestically funded - Market evolution: By end 2024, newer vaccines (HPV, PCV, Rotavirus) are projected to represent 65% of procurement spending 💡 Interesting market dynamics: - Quality matters: 9 out of 10 EPI products have World Health Organization prequalification - Local manufacturing emphasis: Strong preference for domestic products or technology transfers - Cultural consideration: Halal certification plays a crucial role in vaccine acceptance Despite pandemic-related setbacks in coverage rates, Indonesia's commitment to immunization remains strong, with substantial investments in new vaccine introductions and health system strengthening. #GlobalHealth #Vaccines #PublicHealth #Healthcare #Indonesia #MarketAccess #Immunization https://lnkd.in/gxjmMeSD
Watching How Climate will Change Health @FINNPartners | Rotarian | dog dad | whack-a-mole expert | keen listener | defiant optimist despite evidence to contrary
1dImpressive to see Indonesia’s strong commitment to expanding its immunization efforts, especially with a focus on local manufacturing and cultural considerations.